MILTENYI CORPORATE SESSION Cutting-edge cell and gene therapy – overcoming obstacles from point-of-care to centralized manufacturing
Wednesday, May 31, 2023 03:00 PM - 04:30 PM
Room 252B
Corporate Session
Cutting-edge cell and gene therapy – overcoming obstacles from point-of-care to centralized manufacturing
Chair
Prof. Jérôme Larghero, Director of MEARY Center of Cell and Gene Therapy, and of the Department of Biotherapies, St. Louis Hospital, AP-HP, Paris, France
Speakers
Dr. Michael Aigner, Head of Production GMP Cell Processing Unit, University Hospital Erlangen, Germany
Dr. Jason Bock, Chief Executive Officer, CTMC, USA
Alden Ladd, Associate Director of Immune Cell Process Development, Beam Therapeutics, USA
The development and manufacturing of cell and gene therapies are complex with demanding requirements. Join us to hear how to overcome the challenges in hospital, CDMO, and biotech environments to ensure efficient manufacturing from pivotal studies to commercialization of cell and gene therapies.
Chair
Prof. Jérôme Larghero, Director of MEARY Center of Cell and Gene Therapy, and of the Department of Biotherapies, St. Louis Hospital, AP-HP, Paris, France
Speakers
Dr. Michael Aigner, Head of Production GMP Cell Processing Unit, University Hospital Erlangen, Germany
Dr. Jason Bock, Chief Executive Officer, CTMC, USA
Alden Ladd, Associate Director of Immune Cell Process Development, Beam Therapeutics, USA
The development and manufacturing of cell and gene therapies are complex with demanding requirements. Join us to hear how to overcome the challenges in hospital, CDMO, and biotech environments to ensure efficient manufacturing from pivotal studies to commercialization of cell and gene therapies.